Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![overnight_stock Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1941151648589434880.png) overnightstocks.com [@overnight_stock](/creator/twitter/overnight_stock) on x XXX followers
Created: 2025-07-23 06:01:04 UTC

📢 Earnings & News Update | Wednesday, July 23, 2025

• $UCG UniCredit raises FY25 profit guidance to €10.5B after Q2 net income beats at €3.34B (vs. €2.51B est.). Plans ≥€9.5B in 2025 payouts.

• $HO Thales misses Q2 revenue (€5.31B vs. €5.41B est.), but lifts FY revenue guidance to €21.8–22B.

• $267270.KQ HD Hyundai Infracore beats Q2 estimates with ₩1.18T revenue (vs. ₩1.12T est.) and ₩105.8B operating profit.

• $VH2 Friedrich Vorwerk grows H1 revenue by XX% to €303M, raises FY guidance to €610–650M. Order backlog at €1.105B.

• $ROG Roche receives EU approval for cancer drug Itovebi (with Palbociclib + Fulvestrant) in PIK3CA-mutated breast cancer + CE mark for Alzheimer test Elecsys pTau181.


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947899746066022511/c:line.svg)

**Related Topics**
[q2](/topic/q2)
[$042670ks](/topic/$042670ks)
[hyundai](/topic/hyundai)
[$267270kq](/topic/$267270kq)
[$ho](/topic/$ho)
[$ucgmi](/topic/$ucgmi)
[$ucg](/topic/$ucg)

[Post Link](https://x.com/overnight_stock/status/1947899746066022511)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

overnight_stock Avatar overnightstocks.com @overnight_stock on x XXX followers Created: 2025-07-23 06:01:04 UTC

📢 Earnings & News Update | Wednesday, July 23, 2025

• $UCG UniCredit raises FY25 profit guidance to €10.5B after Q2 net income beats at €3.34B (vs. €2.51B est.). Plans ≥€9.5B in 2025 payouts.

• $HO Thales misses Q2 revenue (€5.31B vs. €5.41B est.), but lifts FY revenue guidance to €21.8–22B.

• $267270.KQ HD Hyundai Infracore beats Q2 estimates with ₩1.18T revenue (vs. ₩1.12T est.) and ₩105.8B operating profit.

• $VH2 Friedrich Vorwerk grows H1 revenue by XX% to €303M, raises FY guidance to €610–650M. Order backlog at €1.105B.

• $ROG Roche receives EU approval for cancer drug Itovebi (with Palbociclib + Fulvestrant) in PIK3CA-mutated breast cancer + CE mark for Alzheimer test Elecsys pTau181.

XX engagements

Engagements Line Chart

Related Topics q2 $042670ks hyundai $267270kq $ho $ucgmi $ucg

Post Link

post/tweet::1947899746066022511
/post/tweet::1947899746066022511